Arrowhead Pharmaceuticals Inc. (ARWR) Fell Out Of Favor With Hedge Funds
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Arrowhead Pharmaceuticals Inc. (ARWR)
Market is closed
News
- First
- << Previous
- 31 - 40
- Next >>
Did Hedge Funds Make The Right Call On Arrowhead Pharmaceuticals Inc. (ARWR) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Is Arrowhead Pharmaceuticals Inc. (ARWR) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Have Never Been This Bullish On Arrowhead Pharmaceuticals, Inc. (ARWR)
Coronavirus is probably the #1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW.
Did Hedge Funds Drop The Ball On Arrowhead Research Corp (ARWR) ?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money managers and analyze their...
Hedge Funds Have Never Been More Bullish On Arrowhead Pharmaceuticals, Inc. (ARWR)
Is Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock.
Hedge Fund and Insider Trading News: Ken Griffin, Tom Steyer, Amber Capital, Acadia Pharmaceuticals Inc. (ACAD), and More
PARIS (Reuters) - Activist shareholder Amber Capital, which is being sued by Lagardere (LAGA.PA), said on Monday the lawsuit was baseless and it would continue to seek strategy and management changes ...
Is Arrowhead Pharmaceuticals Inc (ARWR)’s Recently Published U.S. Patent Application A Blockbuster?
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) business model of going after extrahepatic targets and establishing first mover advantage has the potential to be amplified by gaining patent protection for...
Hedge Funds Have Never Been This Bullish On Arrowhead Pharmaceuticals, Inc. (ARWR)
A market surge in the first quarter, spurred by easing global macroeconomic concerns and Powell's pivot ended up having a positive impact on the markets and many hedge funds as a result.
Here's What Hedge Funds Think About Arrowhead Pharmaceuticals, Inc. (ARWR)
Is Arrowhead Pharmaceuticals, Inc.
- First
- << Previous
- 31 - 40
- Next >>
Billionaire Hedge Funds
